Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares

Part of paid clinical trials in Phoenix, Arizona.

Sponsor
Castle Biosciences Incorporated
Study ID
NCT07645820
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
12 Years - 89 Years
Healthy Volunteers
Not accepted

Interventions

  • Nevisense electrical impedance spectroscopy — DEVICE
    The NevisenseGo device will collect skin measurements from people with atopic dermatitis (AD) to see if it can effectively predict a flare in disease.

Study Details

This study will collect skin measurements from people with atopic dermatitis (AD) using the investigational Nevisense Go device. Participants aged 12 to 89 years with a history of AD flares will use the device at home for about 90 days. Participants will complete device measurements, electronic diary entries, and up to five in-person study visits. The study is based on the idea that changes in skin barrier function may occur before an AD flare becomes visible or symptoms begin. Information collected during the study, including device measurements, diary entries, and investigator assessments, will be used to evaluate whether these changes may help estimate the likelihood of an AD flare before visible signs or symptoms occur.

Key Dates

Start date
May 29, 2026
Status verified
Jun 2026
Primary completion
Apr 1, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
450 participants (estimated)

Primary Outcome Measure

Relationship between skin measurements and subsequent atopic dermatitis flares [ Time Frame: Measurements taken over 90 days, 5 days a week ]

Central Contacts

Locations (4)

FacilityCityStateZIPSite coordinators
U.S. Dermatology PartnersPhoenixArizona85006
Margaret Kessler, MD (PRINCIPAL_INVESTIGATOR)
Las Vegas DermatologyLas VegasNevada89144
David Cotter, MD, PhD (PRINCIPAL_INVESTIGATOR)
StracSkin, PLLCPortsmouthNew Hampshire03801
Abel Jarell, MD, FAAD (PRINCIPAL_INVESTIGATOR)
Harrison Institute for Clinical ResearchMissouri CityTexas77459
Harrison Nguyen, MD, MBA, MPH, DTM&H FAAD

Find similar trials in Phoenix, AZ

Related Studies